¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Hipertensión y Riesgo Vascular

Suscribe to the journal

Buscar en

Hipertensión y Riesgo Vascular

Toda la web

Inicio Hipertensión y Riesgo Vascular Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and ...

ISSN: 1889-1837

See more Open Access Option

Hipertensión y Riesgo Vascular ha recibido Factor de Impacto (JCR) por primera vez en 2023. Guía para autores - Envío de manuscritos

Indexed in:

Web of Science, Index Medicus/MEDLINE, SCOPUS, IBECS, IME

See more

Follow us:

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

1.2

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

1.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.234

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.46

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis

Suplementación de vitamina D3 en pacientes con COVID-19 con enfermedad cardiovascular y disbiosis intestinal

R.L. Sanza, F. Garcíab, A. Gutierrezc, S. García Menendeza, F. Inserrad, L. Ferderd, W. Manuchaa,

Corresponding author

wmanucha@yahoo.com.ar
wmanucha@fcm.uncu.edu.ar

Corresponding author.

a Área de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo e IMBECU-CONICET, Mendoza, Argentina

b Clínica Sanatorio Mitre, Mendoza, Argentina

c Clínica de Cuyo, Mendoza, Argentina

d Universidad Maimónides, CABA, Buenos Aires, Argentina

Read

170

Times
was read the article

14

Total PDF

156

Total HTML

Share statistics

Article information

ISSN: 18891837
Original language: English

DOI:10.1016/j.hipert.2024.04.002

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	4	0	4
2024 October	10	0	10
2024 September	58	5	63
2024 August	32	5	37
2024 July	17	1	18
2024 June	35	3	38

Follow this link to access the full text of the article